CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 150 enrolled
Drug / intervention
Artificial shrinkageprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02988544
NCT02988544N/ACompleted
CompareCT.gov

Artificial Shrinkage of Fresh Blastocyst: Impact on Success Rates in Assisted Reproductive Technology

University Hospital, Montpellier·interventional·Posted Dec 9, 2016·Updated Apr 24, 2024

In Brief

A clinical study evaluating Artificial shrinkage for Infertility Assisted Reproductive Technology. Completed, enrolled 150 participants across 1 site.

Detailed Summary

The aim of the study is to determine if collapsing an embryo (or making it fold compactly by taking away its fluid) before the transfer in the uterine cavity improves pregnancy rates in assisted reproductive technology (ART). Women coming to our ART center will be randomized in two groups : the collapsing group and a control group. Pregnancy rates will be compared in the two groups. A biomarker (cell free DNA) will also be determined in each group and correlated to pregnancy occurrence.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfertility Assisted Reproductive Technology
CountriesFrance
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedDec 9, 2016
Enrollment StartMay 20, 2018
Primary CompletionAug 20, 2021
Study CompletionFeb 22, 2022
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 9.6 years ago

Interventions

Artificial shrinkageprocedure

Artificial shrinkage of blastocyst